Alaunos Therapeutics (TCRT) vs Valion Bio (VBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alaunos Therapeutics is the larger company by market cap ($2.3 million vs $2.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TCRT | VBIO |
|---|---|---|
| Share price | $0.781 | $2.21 |
| Market cap | $2.29M | $1.96M |
| 1-day change | -6.70% | +0.91% |
| EPS (TTM) | $-1.76 | $-177.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.50 | $76.50 |
| 52-week low | $0.72 | $2.05 |
| Distance from 52-week high | -82.64% | -97.11% |
| Average volume | 797.20K | 1.46M |
| Shares outstanding | 2.93M | 887.59K |
| Employees | 1 | 52 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Alaunos Therapeutics
TCRT stock →Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.
Healthcare · Biotechnology · 1 employees
About Valion Bio
VBIO stock →Valion Bio, Inc. operates as a late-stage biopharmaceutical company.
Healthcare · Biotechnology · 52 employees
TCRT vs VBIO FAQ
Which is bigger, Alaunos Therapeutics or Valion Bio?
Alaunos Therapeutics (TCRT) is larger, with a market capitalization of $2.29M compared with $1.96M for Valion Bio (VBIO).
Are Alaunos Therapeutics and Valion Bio in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.